A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight.

The cessation of GLP-1RAs is linked to a 60% weight regain within a year, emphasizing the importance of tailored strategies ...

Evelyn Parr received funding from the Australian government's Medical Research Future Fund and the Diabetes Australia Research Program for work on time-restricted eating. Intermittent fasting has ...

Retrospective cohorts show GLP-1 RA exposure yields ~5% relative weight reduction and an apparent OS advantage, while ...

Gubra's partner AbbVie today announced positive topline results from the 12 and 13-weeks Phase 1 Multiple Ascending Dose (MAD) trial showing that ABBV-295 was well tolerated with a dose-dependent sign ...

Penn State's Josh Barr (19-0) reached the 2025 NCAA tournament finals as a freshman and has earned bonus point wins in all of ...

GLP-1 medications mimic a natural hormone that controls appetite, blood sugar, and digestion. Monthly costs range from $199 to over $1,300, depending on the specific medication and insurance coverage.

Dr Arun Sharma India is facing a silent but rapidly growing epidemic – obesity and lifestyle-related diseases. Once ...

A 40-year fitness trainer shares 4 daily knee exercises after 55 that rebuild strength better than resistance bands.

52-week follow-up data from type 1 diabetes (“T1D”) patients in COVALENT-112 who completed ≥80% of protocol-specified dosing with the read-out expected in the second quarter of 2026. 26-week primary ...

Ehlers-Danlos syndrome (EDS) hypermobility type (hEDS) is an inherited connective tissue disorder that is characterised by ...

Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; ...